| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PHAT | Phathom Pharmaceuticals, Inc. | Director | $132K | Jun 3, 2025 | ||
| AVTX | Avalo Therapeutics, Inc. | Chief Executive Officer, Director | Oct 1, 2021 | |||
| SAGE | Sage Therapeutics, Inc. | Director | Jul 31, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|